BIIB - Biogen

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by T0rm3nted, Apr 9, 2016.

  1. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Biogen
    [​IMG]

    [​IMG]

    Biogen (BIIB) is an American global biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide.
     
    #1 T0rm3nted, Apr 9, 2016
    Last edited by a moderator: Jun 7, 2016
  2. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Reported before open today (4/21/16):
    Earnings: EPS $4.79 and revenue $2.727B
    Estimates: EPS $4.48 and revenue $2.758B
     
  3. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,536
    Likes Received:
    2,996
    Selling off pre market
     
  4. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Continued selling off throughout the day and closed Down 12.6%

    upload_2016-6-7_19-48-0.png
     
  5. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Reported before open today (7/21/16)
    Earnings: EPS $5.21 Revenue $2.89B
    Estimates: EPS $4.68 Revenue $2.79B

    Up 5.06% pre-market so far
     
  6. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,536
    Likes Received:
    2,996
    Biogen spiking on takeover speculation.

    Stock was briefly halted for volatility.
     
    Tiptopptrader likes this.
  7. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,536
    Likes Received:
    2,996
    Looks like its going to be a strong close!
     
  8. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,536
    Likes Received:
    2,996
    Looking for a move over $320 to get the bull cap back on.

    CAMBRIDGE, Mass.--(BUSINESS WIRE)--
    TodayBiogen(NASDAQ: BIIB) announced that aducanumab, its
    investigational treatment for early Alzheimers disease (AD), was
    granted Fast Track designation by the U.S. Food and Drug Administration
    (FDA). The FDAs Fast Track program supports the development of new
    treatments for serious conditions with an unmet medical need such as
    Alzheimers disease.
     
  9. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Reported before open today (10/26/16)
    Earnings: EPS $5.19 Revenue $2.96B
    Estimates: EPS $4.97 Revenue $2.91B

    Up 3.66% today
     
  10. T0rm3nted

    T0rm3nted Moderator
    Staff Member

    Joined:
    Apr 2, 2016
    Messages:
    8,056
    Likes Received:
    2,929
    Analyst Upgrade/Downgrade Update

    Brokerage firm: Leerink Partners
    Change: Upgrade
    Previous Rating: Market Perform
    Current Rating: Outperform
    Previous Price Target: N/A
    Current Price Target: N/A

    Analyst Upgrade/Downgrade Update

    Brokerage firm: Piper Jaffray
    Change: Upgrade
    Previous Rating: Neutral
    Current Rating: Overweight
    Previous Price Target: N/A
    Current Price Target: N/A
     
  11. aaa

    aaa Member

    Joined:
    Dec 21, 2016
    Messages:
    117
    Likes Received:
    3
    Raymond James raises BIIB PT to $386 from $375
     
  12. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,536
    Likes Received:
    2,996
    Finally some relief to the upside, this thing was going down for several days now.
     
  13. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,536
    Likes Received:
    2,996
    Good move here pre market, this is going to test the downtrend today.
     
  14. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    3,338
    Likes Received:
    2,684
    Looks like it's going for a breakout

    Weekly chart:
    [​IMG]
     
  15. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,536
    Likes Received:
    2,996
    Nice catch, lets see if it follows through this week!
     
  16. anotherdevilsadvocate

    anotherdevilsadvocate Well-Known Member

    Joined:
    Apr 3, 2016
    Messages:
    3,338
    Likes Received:
    2,684
    Facing the resistance here
    [​IMG]
     
    T0rm3nted and Onepoint272 like this.
  17. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,536
    Likes Received:
    2,996
    Holy moly!

    Look at the action here today!
     
  18. StockJock-e

    StockJock-e Brew Master
    Staff Member

    Joined:
    Apr 3, 2016
    Messages:
    8,536
    Likes Received:
    2,996
    Biogen shares leap as Alzheimer's drug shows potential to slow disease
     
    T0rm3nted likes this.
  19. bigbull

    bigbull Active Member

    Joined:
    Jul 12, 2016
    Messages:
    253
    Likes Received:
    130
    A trade above $377.30 into year-end keeps the momentum trade alive, otherwise it best to hold off.
    $351.40 is a key level. If it holds into Labor day, a trend reversal is in effect, changing the narrative from a `sell into the rip` to a `buy into the dip story`.

    There is strong support at $317.55 in the first half of next year based on the current move. That's the ideal entry point if the trade were present some weakness.

    $364.43 to $374.00 is the price band, that if exceeded, puts the momentum back into play.

    BIIB and AMGN are the safest, and perhaps best plays in the sector.


     
    T0rm3nted likes this.
  20. Stockaholic

    Stockaholic Content Manager

    Joined:
    Mar 29, 2016
    Messages:
    13,767
    Likes Received:
    7,038
    Biogen (BIIB) Set to Gap up 40% on Earnings/Drug News
    Tue, Oct 22, 2019

    Biogen (BIIB) shares are currently set to gap higher by 41% this morning due to earnings and positive news for its Alzheimer's drug. A 40%+ gap on earnings is extremely rare, but we can find historical occurrences very easily using our Earnings Explorer tool. Seeing how prior stocks performed following big gaps up or down on earnings is one of the many useful ways to use our Earnings Explorer. Below are the results from a quick screen we ran that found all stocks reporting earnings since the start of 2017 that opened higher by at least 40% on the day. As shown, there have only been 12 occurrences, and the average gap up at the open for these 12 names was +65.27%.

    After their initial massive gap higher, these 12 stocks averaged a decline of 5.75% from the open to the close of trading, so it appears that traders look to book some profits. However, the average is actually skewed by DCIX, which shows up twice on the list with back-to-back gaps up of 50%+ back in 2017. In July 2017, DCIX opened higher by 57% only to trade down 42% from the open to the close for a full-day decline of 9%. In November 2017, DCIX opened up 85% only to fall 32% from the open to the close. On its November 2017 report, at least DCIX still managed to close higher by 25% for the full day.

    All in all, 7 of the 12 stocks that have gapped up 40%+ on earnings since 2017 have continued higher from the open to the close. One thing for sure is that BIIB would be the highest priced stock to gap up 40%+ on earnings since at least 2001 when our database begins. No stock above $200/share has gapped up even 30%+ following an earnings report. The only $100+ stocks to gap up 30%+ since 2001 are Netflix (NFLX) and First Solar (FSLR). Netflix opened higher by 39% following its January 2013 report (when it had closed at $103/share the prior day) and it gained another 2% from the open to the close that day. FSLR closed at $167/share on 11/7/07 and then gapped up 32% the next morning following earnings. That day FSLR continued higher by 1.5% from the open to the close to finish the day up 34.3%. Biogen (BIIB) closed yesterday at $223.51 and is currently trading between $305-$320 in the pre-market.

    [​IMG]
     

Share This Page